Look for:

Our offer for

INCYTE CORP


ISIN:
US45337C1027
WKN:
45337C102

2024/03/28 08:05:43
Price
52.56 EUR
Difference 0.00% (0.00)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)11,840 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)52.52 EUR (500)
Ask (Ask size)52.58 EUR (500)
Open52.56 EUR
High52.56 EUR
Low52.56 EUR
Close (prev. day)52.56 EUR
VWAP56.12 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: INCYTE CORPPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 08:05:43
Price
52.56 EUR
Difference 0.00% (0.00)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)11,840 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)52.52 EUR (500)
Ask (Ask size)52.58 EUR (500)
Open52.56 EUR
High52.56 EUR
Low52.56 EUR
Close (prev. day)52.56 EUR
VWAP56.12 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-6.14%-20.04%-22.47%
Perf (abs.)-3.44-13.17-15.23
Beta0.290.430.50
Volatility24.8822.0522.30
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)53.02 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)54.35 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)54.13 EUR (0)
Ø price 250 days | Ø volume 250 days (pcs.)56.70 EUR (0)
YTD High | date61.12 EUR (2024/01/03)
YTD Low | date52.56 EUR (2024/03/27)
52 Weeks High | date68.38 EUR (2023/04/18)
52 Weeks Low | date48.22 EUR (2023/11/29)

All listings for INCYTE CORP

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/03/2816:3552.70 EUR0.002
Stuttgart2024/03/2815:3052.40 EUR0.003
Nasdaq2024/03/2818:0656.75 USD32.1911,085
Munich2024/03/2808:0552.56 EUR0.001
London Stock Exchange2023/02/1618:0379.48 USD0.101
Hanover2024/03/2808:1052.62 EUR0.001
Frankfurt2024/03/2808:0152.54 EUR0.001
Euronext Milan MTF Trading After Hours2024/03/2018:1353.60 EUR0.001
Euronext Milan MTF Global Equity Market2024/03/2817:4452.66 EUR0.001
Duesseldorf2024/03/2816:3052.62 EUR0.004
Berlin2024/03/2817:4252.56 EUR0.0014
BX Swiss2023/12/1418:0055.618 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=130964&ID_TYPE_IMAGE_LOGO=2

Contact Details

INCYTE CORP.
- -
1801 Augustine Cut-Off - 19803 Wilmington
Telefon: +1-302-498-6700
Fax: +
E-mail: -

PDF Downloads

Company report: INCYTE CORPPDF Download

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.

Members of Management Board

Edmund HarriganMember of Board of Directors
Jacqualyn FouseMember of Board of Directors
Katherine HighMember of Board of Directors
Otis BrawleyMember of Board of Directors
Susanne Antonie SchaffertMember of Board of Directors
Jean-Jacques BienaiméMember of Board of Directors
Julian BakerMember of Board of Directors
Paul ClancyMember of Board of Directors
Hervé HoppenotChairman of Managing Board
Dashyant DhanakMember of Executive Committee
Lothar H. FinkeMember of Executive Committee
Barry P. FlannellyMember of Executive Committee
Christiana StamoulisMember of Executive Committee
Jonathan E. DickinsonMember of Executive Committee
Maria E. PasqualeMember of Executive Committee
Michael MorrisseyMember of Executive Committee
Paula J. SwainMember of Executive Committee
Steven H. Stein, M.D.Member of Executive Committee
Vijay Iyengar, M.D.Member of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer